UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer

Journal of controlled release, 2018-09, Vol.285, p.187-199

2018

Volltextzugriff (PDF)

Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models

International journal of pharmaceutics, 2024-05, Vol.656, p.124091-124091, Article 124091

2024

Volltextzugriff (PDF)

Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy

ACS applied materials & interfaces, 2024-08, Vol.16 (34), p.44528-44537

2024

Volltextzugriff (PDF)

Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration

International journal of nanomedicine, 2024-01, Vol.19, p.8603-8620

2024

Volltextzugriff (PDF)

Harnessing transcription factor-driven ROS for synergistic multimodal lung cancer treatment

Journal of controlled release, 2024-10, Vol.374, p.489-504

2024

Volltextzugriff (PDF)

Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer

European journal of pharmaceutics and biopharmaceutics, 2024-08, Vol.201, p.114386, Article 114386

2024

Volltextzugriff (PDF)

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

Journal of clinical oncology, 2019-05, Vol.37 (15), p.1296-1304

2019

Volltextzugriff (PDF)

Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes

Angewandte Chemie International Edition, 2021-03, Vol.60 (10), p.5394-5399

International ed. in English, 2021

Volltextzugriff (PDF)

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Annals of oncology, 2018-04, Vol.29 (4), p.959-965

2018

Volltextzugriff (PDF)

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

The Lancet (British edition), 2019-05, Vol.393 (10184), p.1948-1957

2019

Volltextzugriff (PDF)

Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells

International journal of pharmaceutics, 2020-06, Vol.583, p.119393, Article 119393

2020

Volltextzugriff (PDF)

First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies

Investigational new drugs, 2021-08, Vol.39 (4), p.1047-1056

2021

Volltextzugriff (PDF)

Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel

International journal of pharmaceutics, 2019-11, Vol.571, p.118699, Article 118699

2019

Volltextzugriff (PDF)

Shape of Nanoparticles as a Design Parameter to Improve Docetaxel Antitumor Efficacy

Bioconjugate chemistry, 2018-04, Vol.29 (4), p.1302-1311

2018

Volltextzugriff (PDF)

Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes

Colloids and surfaces, B, Biointerfaces, 2018-12, Vol.172, p.213-223

2018

Volltextzugriff (PDF)

Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

Oral oncology, 2018-12, Vol.87, p.49-57

2018

Volltextzugriff (PDF)

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

The lancet oncology, 2019-10, Vol.20 (10), p.1395-1408

2019

Volltextzugriff (PDF)

Construction and anti-tumor activities of disulfide-linked docetaxel-dihydroartemisinin nanoconjugates

Colloids and surfaces, B, Biointerfaces, 2020-07, Vol.191, p.111018, Article 111018

2020

Volltextzugriff (PDF)

Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy

Nanomedicine (London, England), 2018-11, Vol.13 (21), p.2759-2776

2018

Volltextzugriff (PDF)

Docetaxel-tethered di-Carboxylic Acid Derivatised Fullerenes: A Promising Drug Delivery Approach for Breast Cancer

AAPS PharmSciTech, 2024-10, Vol.25 (7), p.233, Article 233

2024

Volltextzugriff (PDF)

Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy

Carbohydrate polymers, 2021-09, Vol.267, p.118160, Article 118160

2021

Volltextzugriff (PDF)

Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery

AAPS PharmSciTech, 2020-10, Vol.21 (7), p.280, Article 280

2020

Volltextzugriff (PDF)

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-01, Vol.393 (10167), p.156-167

2019

Volltextzugriff (PDF)

1 – 25 von 3.802

Suche als RSS-Feed

Aktive Filter

SpracheKoreanisch

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.636)
Mit Volltextzugriff
(3.403)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(3.717)
Science & Technology
(3.453)
Life Sciences & Biomedicine
(3.340)
Docetaxel
(3.168)
Oncology
(2.647)
Middle Aged
(2.593)
Aged
(2.280)
Adult
(2.035)
Male
(1.863)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(1.819)
Taxoids - Administration & Dosage
(1.704)
Chemotherapy
(1.379)
Breast Neoplasms - Drug Therapy
(1.243)
Biological And Medical Sciences
(1.161)
Medical Sciences
(1.159)
Treatment Outcome
(1.153)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(984)
Tumors
(900)
Breast Cancer
(864)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.801)
EZB Electronic Journals Library
(1.763)
Ingenta
(1.763)
Journals@Ovid Complete
(1.675)
SpringerLink Journals - AutoHoldings
(841)
IngentaConnect Journals
(765)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(680)
Elsevier ScienceDirect Journals Complete
(609)
NUS Single-Journal Subscriptions
(585)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(465)
Wiley Online Library
(384)
Wiley Online Library
(219)
Taylor & Francis Journals
(188)
Nature Journals
(174)
Taylor & Francis Current Content Access
(162)
Taylor & Francis Journals Complete
(131)
Springer Book Series (Lecture Notes)
(106)
Nexis Uni
(105)
Oxford Journals
(101)
Oxford Journals 2020 Medicine
(86)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(279)
Cancer Chemotherapy And Pharmacology
(198)
Anticancer Research
(139)
British Journal Of Cancer
(121)
Breast Cancer Research And Treatment
(96)
Anti-Cancer Drugs
(94)
Lung Cancer
(90)
European Journal Of Cancer
(84)
Cancer
(81)
Bmc Cancer
(62)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Precisely albumin-hitchhiking tumor cell-activated reduction/oxidation-responsive docetaxel prodrugs for the hyperselective treatment of breast cancer

Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models

Glycopolymeric Micellar Nanoparticles for Platelet-Mediated Tumor-Targeted Delivery of Docetaxel for Cancer Therapy

Co-Delivery of Docetaxel and Curcumin Functionalized Mixed Micelles for the Treatment of Drug-Resistant Breast Cancer by Oral Administration

Harnessing transcription factor-driven ROS for synergistic multimodal lung cancer treatment

Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer

Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial

Enhanced docetaxel delivery using sterically stabilized RIPL peptide-conjugated nanostructured lipid carriers: In vitro and in vivo antitumor efficacy against SKOV3 ovarian cancer cells

First‐in‐human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies

Nanoparticles from Gantrez® AN-poly(ethylene glycol) conjugates as carriers for oral delivery of docetaxel

Shape of Nanoparticles as a Design Parameter to Improve Docetaxel Antitumor Efficacy

Improved antitumor efficacy and reduced toxicity of docetaxel using anacardic acid functionalized stealth liposomes

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis

Construction and anti-tumor activities of disulfide-linked docetaxel-dihydroartemisinin nanoconjugates

Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy

Docetaxel-tethered di-Carboxylic Acid Derivatised Fullerenes: A Promising Drug Delivery Approach for Breast Cancer

Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy

Folate-Targeted Cholesterol-Grafted Lipo-Polymeric Nanoparticles for Chemotherapeutic Agent Delivery

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Aktive Filter

Suchergebnisse filtern